Product Images Atorvaliq
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Atorvaliq NDC 46287-030 by Cmp Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a graph showing the cumulative incidence of something over time, possibly a medical study or clinical trial. There are percentages listed on the y-axis and years on the x-axis. The values on the y-axis start at 15 and go up to 40. There is also a line labeled "HR-084" with a value of 25 at the 5-year mark. A p-value of 0.0005 is listed.*
The text is a table showing the percentage of subjects who experienced an event for two different medications: Aorvastatin 10 mg and Aorvastatin 80 mg. It also includes an HR (hazard ratio) value and the p-value for the comparison between the two medications. The table also shows the time to the first major cardiovascular endpoint in years.*
Recommended dosage information for Atorvastatin (calcium equivalent to 4mg per mL) oral suspension is available in the Praseribing Information. The oral suspension comes in a 150mL bottle and should be stored at controlled room temperature. The suspension must be shaken well before use and should be consumed within 60 days of opening. Dispensing to patients should be done in the original packaging. This text also includes lot number and expiration date information but due to errors, some characters are not readable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.